Evidence map›Paper›PMID 40869336›Full record

ReviewInternational journal of molecular sciences2025

New Frontiers in 3D Printing Using Biocompatible Polymers.

Nagireddy Poluri, Jacob Carter, John Grasso, Walter Miller, Matthew Leinbach, Frederick Durant, Riley Benbrook, Assa John, Allan Wang, Xiao Hu

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nagireddy PoluriDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.ORCID 0009-0003-6571-045X
Jacob CarterDepartment of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA.
John GrassoDepartment of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA.
Walter MillerDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.
Matthew LeinbachDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.
Frederick DurantDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.
Riley BenbrookDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.
Assa JohnDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.
Allan WangDepartment of Biological and Biomedical Sciences, Rowan University, Glassboro, NJ 08028, USA.
Xiao HuDepartment of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA.ORCID 0000-0002-2579-2820

Funding

U.S. National Science Foundation CMMI-2037097
6 · The paper itself

Abstract

Biocompatible polymers have emerged as essential materials in medical 3D printing, enabling the fabrication of scaffolds, tissue constructs, drug delivery systems, and biosensors for applications in and on the human body. This review aims to provide a comprehensive overview of the current state of 3D-printable biocompatible polymers and their composites, with an emphasis on their processing methods, properties, and biomedical uses. The scope of this work includes both natural and synthetic biocompatible polymers, polymer-nanocomposite systems, and bioinks that do not require photo initiators. The relevant literature was critically examined to classify materials by type, evaluate their compatibility with major 3D printing techniques such as stereolithography, selective laser sintering, and fused deposition modeling, and assess their performance in various medical applications. Key findings highlight that reinforced polymer composites, tailored surface chemistries, and hybrid printing strategies significantly expand the range of functional, customizable, and affordable biomedical devices. This review concludes by discussing present-day applications and emerging trends, underscoring that 3D-printable biocompatible polymers are rapidly transitioning from research to clinical practice, offering transformative potential for patient-specific healthcare solutions.

Indexed as

Biocompatible MaterialsPolymersPrinting, Three-DimensionalAnimalsBioprintingDrug Delivery SystemsHumansTissue EngineeringTissue ScaffoldsBiocompatible MaterialsPolymers3D printingbiopolymerbioprintingbiosensorcrosslinkingdrug deliverynanocompositestissue regeneration

Identifiers

PMID40869336
PMCPMC12386597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.